Market growth influenced due to following factors-
- Increasing prevalence of cardiovascular diseases and blood disorders.
- Technological advancements in coagulation analyzers.
- Rising geriatric population.
Global market size-
According to market research report the Coagulation Analyzers Market is projected to reach $5.0 billion by 2025, at a CAGR of 5.7%.
Leading Players-
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Hemostasis Analyzer Market.
Top Market Segments-
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the Hemostasis Analyzer Market is the optical technology. This segment accounted for the largest share of the market in 2019.
Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market.
For Details, Download PDF Brochure
Geographic Overview -
North America (comprising the US and Canada) accounted for the largest share of the global Coagulation Analyzer Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America.